Suchergebnisse
Suchergebnisse:
Vor 5 Tagen · 3SBio Inc. ist eine Investment-Holding, die sich hauptsächlich mit der Entwicklung, Herstellung, Vermarktung und dem Verkauf von pharmazeutischen Produkten beschäftigt. Zu den Hauptprodukten des Unternehmens gehören rekombinantes menschliches Thrombopoietin (rhTPO), Tumor-Nekrose-Faktor (TNF)?-Inhibitor-Produkte und rekombinantes ...
Vor 2 Tagen · 3SBio Inc. commences an Equity Buyback for 243,892,041 shares, representing 10% of its issued share capital, under the authorization approved on June 20, 2023. Mar. 27 CI
Vor 2 Tagen · 3SBio Inc.: Forcasts, revenue, earnings, analysts expectations, ratios for 3SBio Inc. Stock | 1530 | KYG8875G1029.
Vor 5 Tagen · 3SBio Inc.: Trading strategies, financial analysis, commentaries and investment guidance for 3SBio Inc. Stock | BOERSE MUENCHEN: 83B | BOERSE MUENCHEN
Vor 6 Tagen · Track 3SBio Inc (1530) price, historical values, financial information, price projection, and insights to empower your investing journey | MSN Money.
Vor 5 Tagen · 3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the ...
Vor 4 Tagen · Free stock charts, prices, volume, market data, history, options flow, news, seasonality and more for TRSBF (3sbio inc) on TrendSpider
